Top 6 investors in North America with the biggest sum of Private Equity funding rounds in Genetics/Diagnostics industry over the recent years

Intro

The top 6 investors according to the total money raised in the funding rounds. These are VC funds and corporate investors in North America that have invested in Private Equity stage over the last 2 years. They are actively investing in Genetics/Diagnostics industry.

Amount of money raised in Genetics/Diagnostics funding rounds is $669.0M, which is 1.2% of the total amount of money raised in Private Equity rounds in North America over the last 2 years.

Top 6 investors in North America with the biggest sum of Private Equity funding rounds in Genetics/Diagnostics industry over the recent years
data provided by Unicorn Nest

Key takeaways

• Funds Geography – All VCs are located in The United States. New York is the most common state for VCs and it hosts 4 funds. There are also funds from Massachusetts and California. The most common city is New York which is a home to 4 funds. There are also funds from San Francisco and Boston. Top-1 investment geofocus for all VCs is The United States. For the majority of the funds, the country of the funds’ establishment and the country of their most frequent investments coincide.
• Industry Focus –
• Important Years –
• Investments – Usually VCs take part in 2 funding rounds per year, sometimes in 2 – 6 or in 7 – 12. The minimum number of funding rounds for VCs in the sample is 3, the maximum is 101. Average number of funding rounds is 29.0 while median is 12.0.
• Typical Rounds – No grouping tendencies in the amount of investors in the funding rounds were found in this sample. The most common average round size for these funds is less than 100 thousands. Other common ranges are 100-500 million and 100 thousands – 1 million. The most common average multiplicator for portfolio companies at the last known valuation for funds in the sample is 0.0. 1.13, 0.76 and 0.01 are less common.